Filed: 11/14/2024ACC: 0001937964-24-000006
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 44 equity positions with a total reported market value of $366.88M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
44
Positions
$366.88M
Total AUM (reported)
4.82M
Total Shares
Allocation by class
COM$236.59M64.5%
ADR$88.32M24.1%
SPONSORED ADR$24.18M6.6%
SPONSORED ADS$5.56M1.5%
COM NEW$4.79M1.3%
COM PAR $.01$3.86M1.1%
SPON ADS$1.73M0.5%
Portfolio Concentration
Top 3$217.38M59.2%
4–10$79.90M21.8%
11–25$52.97M14.4%
Rest$16.64M4.5%
Top 3 weight
59.2%
Top 10 weight
81.0%
Voting Authority Distribution
Total shares with voting rights: 4.82M
Sole
Full voting authority
4.82M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole44
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings44
Rows:
ELI LILLY & CO
SOLEShares107.59K
TypeSH
Market value$95.32M
25.98%
Sole
107.59K
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares741.74K
TypeSH
Market value$88.32M
24.07%
Sole
741.74K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares532.88K
TypeSH
Market value$33.74M
9.20%
Sole
532.88K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares216.52K
TypeSH
Market value$15.84M
4.32%
Sole
216.52K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$14.86M
4.05%
Sole
190.75K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares274.42K
TypeSH
Market value$13.86M
3.78%
Sole
274.42K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares35K
TypeSH
Market value$9.63M
2.62%
Sole
35K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares18.90K
TypeSH
Market value$8.79M
2.40%
Sole
18.90K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares76.25K
TypeSH
Market value$8.71M
2.38%
Sole
76.25K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares15.14K
TypeSH
Market value$8.21M
2.24%
Sole
15.14K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares87.85K
TypeSH
Market value$7.89M
2.15%
Sole
87.85K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares124.44K
TypeSH
Market value$5.60M
1.53%
Sole
124.44K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares45K
TypeSH
Market value$5.18M
1.41%
Sole
45K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares95.89K
TypeSH
Market value$4.35M
1.19%
Sole
95.89K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares119.49K
TypeSH
Market value$4.29M
1.17%
Sole
119.49K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares148.59K
TypeSH
Market value$4.27M
1.17%
Sole
148.59K
Shared
0.00
None
0.00
MERUS N V
SOLEShares80.17K
TypeSH
Market value$4.01M
1.09%
Sole
80.17K
Shared
0.00
None
0.00
INSMED INC
SOLEShares52.94K
TypeSH
Market value$3.86M
1.05%
Sole
52.94K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares75.30K
TypeSH
Market value$2.56M
0.70%
Sole
75.30K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares45.77K
TypeSH
Market value$2.34M
0.64%
Sole
45.77K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares62.99K
TypeSH
Market value$2.00M
0.54%
Sole
62.99K
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PLC
SOLEShares421.36K
TypeSH
Market value$1.73M
0.47%
Sole
421.36K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares53.93K
TypeSH
Market value$1.73M
0.47%
Sole
53.93K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares15.44K
TypeSH
Market value$1.58M
0.43%
Sole
15.44K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares40K
TypeSH
Market value$1.57M
0.43%
Sole
40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ELI LILLY & COSOLE | COM | 107.59K | SH | $95.32M 25.98% | 107.59K | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 741.74K | SH | $88.32M 24.07% | 741.74K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 532.88K | SH | $33.74M 9.20% | 532.88K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 216.52K | SH | $15.84M 4.32% | 216.52K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $14.86M 4.05% | 190.75K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 274.42K | SH | $13.86M 3.78% | 274.42K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 35K | SH | $9.63M 2.62% | 35K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 18.90K | SH | $8.79M 2.40% | 18.90K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 76.25K | SH | $8.71M 2.38% | 76.25K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 15.14K | SH | $8.21M 2.24% | 15.14K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 87.85K | SH | $7.89M 2.15% | 87.85K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 124.44K | SH | $5.60M 1.53% | 124.44K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 45K | SH | $5.18M 1.41% | 45K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 95.89K | SH | $4.35M 1.19% | 95.89K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 119.49K | SH | $4.29M 1.17% | 119.49K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 148.59K | SH | $4.27M 1.17% | 148.59K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 80.17K | SH | $4.01M 1.09% | 80.17K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 52.94K | SH | $3.86M 1.05% | 52.94K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 75.30K | SH | $2.56M 0.70% | 75.30K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 45.77K | SH | $2.34M 0.64% | 45.77K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 62.99K | SH | $2.00M 0.54% | 62.99K | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PLCSOLE | SPON ADS | 421.36K | SH | $1.73M 0.47% | 421.36K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 53.93K | SH | $1.73M 0.47% | 53.93K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 15.44K | SH | $1.58M 0.43% | 15.44K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 40K | SH | $1.57M 0.43% | 40K | 0.00 | 0.00 |
Page 1 of 2